Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Misleading Statements Common in Online Ads for Compounded GLP-1s

L.A. McKeown

January 20, 2025

News Daily News

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

L.A. McKeown

December 18, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Todd Neale

January 12, 2024

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Michael O'Riordan

February 06, 2020

News Daily News

Coconut Oil Ups LDL Cholesterol Compared With Other Fats: Meta-analysis

Yael L. Maxwell

January 16, 2020

News Daily News

Patients Stop CVD Medications When Their Pharmacy Closes

Michael O'Riordan

April 19, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

News Daily News

BMI Weighs Heavily on All-Cause Mortality Risk, According to a Global Meta-Analysis

Yael L. Maxwell

July 14, 2016

Advertisement

JACC Debuts Data Digest on CV Health in the United States

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

January 2025 Dispatch for the CV Team

Misleading Statements Common in Online Ads for Compounded GLP-1s

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Coconut Oil Ups LDL Cholesterol Compared With Other Fats: Meta-analysis

Patients Stop CVD Medications When Their Pharmacy Closes

One in Two Americans Have Cardiovascular Disease: AHA Stats

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

BMI Weighs Heavily on All-Cause Mortality Risk, According to a Global Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content